SCOPUS 정보 검색 플랫폼

American Journal of Cardiology

Volumn 97, Issue 2 SUPPL. 1, 2006, Pages 20-27

Inflammation in renal disease

(1) Vidt, Donald G a

a LERNER RESEARCH INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ATORVASTATIN; C REACTIVE PROTEIN; ENALAPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL; MEVINOLIN; PLACEBO; PRAVASTATIN; ROSUVASTATIN;

BLOOD PRESSURE; CARDIOVASCULAR RISK; DIALYSIS; HEMODIALYSIS; HUMAN; HYPERTENSION; INFLAMMATION; KAPLAN MEIER METHOD; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 31344458694 PISSN: 00029149 EISSN: None Source Type: Journal
DOI: 10.1016/j.amjcard.2005.11.012 Document Type: Article

Times cited : (57)

References (10)

1
- 2142695734
- Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores
- P.M. Ridker, N. Cook Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores Circulation 109 2004 1955 1959
- (2004) Circulation , vol.109 , pp. 1955-1959
- Ridker, P.M.¹ Cook, N.²

2
- 0035134192
- End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?
- M. Arici, J. Walls End-stage renal disease, atherosclerosis, and cardiovascular mortality is C-reactive protein the missing link? Kidney Int 59 2001 407 414
- (2001) Kidney Int , vol.59 , pp. 407-414
- Arici, M.¹ Walls, J.²

3
- 0035999931
- Inflammation and cardiovascular risk in dialysis patients
- C. Wanner, J. Zimmermann, S. Schwedler, T. Metzger Inflammation and cardiovascular risk in dialysis patients Kidney Int 61 suppl 80 2002 S99 S102
- (2002) Kidney Int , vol.61 , Issue.80 SUPPL.
- Wanner, C.¹ Zimmermann, J.² Schwedler, S.³ Metzger, T.⁴

4
- 0037252331
- C-reactive protein is associated with renal function abnormalities in a non-diabetic population
- E.M. Stuveling, H.L. Hillege, S.J. Bakker, R.O. Gans, P.E. De Jong, D. De Zeeuw C-reactive protein is associated with renal function abnormalities in a non-diabetic population Kidney Int 63 2003 654 661
- (2003) Kidney Int , vol.63 , pp. 654-661
- Stuveling, E.M.¹ Hillege, H.L.² Bakker, S.J.³ Gans, R.O.⁴ De Jong, P.E.⁵ De Zeeuw, D.⁶

5
- 0037117570
- Chronic renal diseases: Renoprotective benefits of renin-angiotensin system inhibition
- G. Remuzzi, P. Ruggenenti, N. Perico Chronic renal diseases renoprotective benefits of renin-angiotensin system inhibition Ann Intern Med 136 2002 604 615
- (2002) Ann Intern Med , vol.136 , pp. 604-615
- Remuzzi, G.¹ Ruggenenti, P.² Perico, N.³

6
- 0345492466
- C-reactive protein and the risk of developing hypertension
- H.D. Sesso, J.E. Buring, N. Rifai, G.J. Blake, J.M. Gaziano, P.M. Ridker C-reactive protein and the risk of developing hypertension JAMA 290 2003 2945 2951
- (2003) JAMA , vol.290 , pp. 2945-2951
- Sesso, H.D.¹ Buring, J.E.² Rifai, N.³ Blake, G.J.⁴ Gaziano, J.M.⁵ Ridker, P.M.⁶

7
- 2542507788
- Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)
- A.C. Spósito, A.P. Mansur, O.R. Coelho, J.C. Nicolau, J. Ramires Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril) Am J Cardiol 83 1999 1497 1499
- (1999) Am J Cardiol , vol.83 , pp. 1497-1499
- Spósito, A.C.¹ Mansur, A.P.² Coelho, O.R.³ Nicolau, J.C.⁴ Ramires, J.⁵

8
- 0037373832
- A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease
- S. Bianchi, R. Bigazzi, A. Caiazza, V.M. Campese A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease Am J Kidney Dis 41 2003 565 570
- (2003) Am J Kidney Dis , vol.41 , pp. 565-570
- Bianchi, S.¹ Bigazzi, R.² Caiazza, A.³ Campese, V.M.⁴

9
- 1842829905
- Rosuvastatin-induced arrest in progression of renal disease
- D.G. Vidt, M.D. Cressman, S. Harris, J.S. Pears, H.G. Hutchinson Rosuvastatin-induced arrest in progression of renal disease Cardiology 102 2004 52 60
- (2004) Cardiology , vol.102 , pp. 52-60
- Vidt, D.G.¹ Cressman, M.D.² Harris, S.³ Pears, J.S.⁴ Hutchinson, H.G.⁵

10
- 1542298565
- The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease: A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study
- V.G. Athyros, D.P. Mikhailidis, A.A. Papageorgiou, A.N. Symeonidis, A.N. Pehlivenidis, V.I. Bouloukos, M. Elisaf The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease a subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study J Clin Pathol 57 2004 728 734
- (2004) J Clin Pathol , vol.57 , pp. 728-734
- Athyros, V.G.¹ Mikhailidis, D.P.² Papageorgiou, A.A.³ Symeonidis, A.N.⁴ Pehlivenidis, A.N.⁵ Bouloukos, V.I.⁶ Elisaf, M.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.